Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Lignoceric Acid has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Ceramides are built from a sphingoid base amide-linked to a fatty acid, and in skin and nerve tissue that fatty acid is frequently a very long chain species including C24. Lignoceric acid is therefore a structural component of the ceramide pool rather than a separate additive. The two are not independent ingredients acting in parallel. Dietary supply of the free acid has not been shown to change tissue ceramide composition in humans.
Every two-carbon extension in fatty acid elongation uses malonyl-CoA, and malonyl-CoA is produced by the biotin-dependent carboxylation of acetyl-CoA. Without adequate biotin the whole elongation chain, including the steps that build C24, loses its substrate. This is textbook cofactor dependence and applies to all chain lengths. It is not a claim that supplemental biotin raises lignoceric acid levels.
Very long chain fatty acids are shortened in the peroxisome by an FAD-dependent acyl-CoA oxidase before the remainder is handed to mitochondria. FAD comes from riboflavin. The cofactor relationship is settled biochemistry and applies to the breakdown side rather than the synthesis side. It says nothing about whether supplementing riboflavin changes circulating levels of this fatty acid.
Peroxisomes cannot fully oxidise a very long chain fatty acid. They shorten it, then the medium chain product is conjugated to carnitine for transport into the mitochondrion where oxidation finishes. Carnitine is the shuttle for that handoff. This describes the normal metabolic route, not an effect of taking carnitine alongside this fatty acid.
Fatty acid elongases extend a range of substrates including both saturated very long chain species and the long chain omega-3 precursors. Supplementation studies that measure the full erythrocyte fatty acid profile report shifts across multiple species when omega-3 intake changes. Those are compositional markers, not clinical outcomes. Which direction any individual species moves depends on the baseline profile.
Barrier repair formulations combine several lipid classes because the skin barrier itself is a mixture of ceramides, cholesterol and free fatty acids. Very long chain saturated fatty acids sit in the free fatty acid fraction of that mixture. Squalane contributes a different, non-polar component. This is topical formulation reasoning rather than evidence for either ingredient taken orally.
A 24-carbon saturated fatty acid has a high melting point and essentially no water solubility, which makes it difficult to formulate and to absorb in free form. Phospholipid emulsification is the standard route to disperse such lipids. This is why the fatty acid usually appears as part of a natural fat or a phospholipid rather than as a free acid supplement. The point is formulation feasibility.
Nothing specific on file for Lignoceric Acid. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 5 we read for Lignoceric Acid. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.